Medigen Vaccine Biologics Corporation (6547.TWO) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Medigen Vaccine Biologics Corporation, with annual and quarterly history.
| Metric | 2025 |
|---|---|
| Valuation | |
| P/E Ratio | -43.90x |
| P/B Ratio | 3.55x |
| P/S Ratio | 20.17x |
| Profitability | |
| Gross Margin | 59.5% |
| Operating Margin | -43.3% |
| Net Margin | -45.9% |
| EBITDA Margin | -20.2% |
| Liquidity | |
| Current Ratio | 12.77x |
| Quick Ratio | 10.64x |
| Leverage | |
| Debt/Equity | 0.08x |
YoY = year-over-year change. Source: FMP..